Finward Bancorp Astrazeneca PLC Transaction History
Finward Bancorp
- $115 Billion
- Q1 2025
A detailed history of Finward Bancorp transactions in Astrazeneca PLC stock. As of the latest transaction made, Finward Bancorp holds 3,098 shares of AZN stock, worth $228,012. This represents 0.2% of its overall portfolio holdings.
Number of Shares
3,098Holding current value
$228,012% of portfolio
0.2%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,419Shares Held
505MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.2 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.99 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.62 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.34 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.3 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...